{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:54:26Z","timestamp":1783612466084,"version":"3.55.0"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Fluoroquinolones are increasingly important for anti-tuberculosis (TB) treatment. Identifying fluoroquinolone resistance (FR) is essential. Using sequencing data from over 16 000 unselected isolates, this first English survey of FR, found it present in 1.4% overall and 23.9% of multidrug-resistant TB. Routine sequencing allows clinically-relevant resistance surveillance and should be widely adopted.<\/jats:p>","DOI":"10.1093\/cid\/ciae560","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T16:39:41Z","timestamp":1731515981000},"page":"660-662","source":"Crossref","is-referenced-by-count":9,"title":["Population-Level Frequency of Fluoroquinolone Resistance by Whole-Genome Sequencing Drug Predictions in <i>Mycobacterium tuberculosis<\/i> Complex Isolates in England From 2017 Through 2023"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8472-7383","authenticated-orcid":false,"given":"Elena","family":"Ferran","sequence":"first","affiliation":[{"name":"National Mycobacterial Reference Service, UK Health Security Agency , Birmingham ,","place":["United Kingdom"]},{"name":"Respiratory Medicine, Royal Free London NHS Foundation Trust , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Chan","sequence":"additional","affiliation":[{"name":"National Mycobacterial Reference Service, UK Health Security Agency , Birmingham ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorann","family":"Sheikh","sequence":"additional","affiliation":[{"name":"National Mycobacterial Reference Service, UK Health Security Agency , Birmingham ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dedicoat","sequence":"additional","affiliation":[{"name":"National Mycobacterial Reference Service, UK Health Security Agency , Birmingham ,","place":["United Kingdom"]},{"name":"Department of Infectious Diseases, University Hospitals Birmingham NHS Foundation Trust , Birmingham ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza","family":"Alexander","sequence":"additional","affiliation":[{"name":"National Mycobacterial Reference Service, UK Health Security Agency , Birmingham ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9473-2215","authenticated-orcid":false,"given":"Ana","family":"Gibertoni-Cruz","sequence":"additional","affiliation":[{"name":"National Mycobacterial Reference Service, UK Health Security Agency , Birmingham ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brown","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Royal Free London NHS Foundation Trust , London ,","place":["United Kingdom"]},{"name":"Division of Medicine, University College London , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0913-3627","authenticated-orcid":false,"given":"Esther","family":"Robinson","sequence":"additional","affiliation":[{"name":"National Mycobacterial Reference Service, UK Health Security Agency , Birmingham ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-4448","authenticated-orcid":false,"given":"Marc","family":"Lipman","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Royal Free London NHS Foundation Trust , London ,","place":["United Kingdom"]},{"name":"Division of Medicine, University College London , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,13]]},"reference":[{"key":"2025031715500293100_ciae560-B1","author":"World Health Organization"},{"key":"2025031715500293100_ciae560-B2","author":"World Health Organization"},{"key":"2025031715500293100_ciae560-B3","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2117166","article-title":"A 24-week, all-oral regimen for rifampin-resistant tuberculosis","volume":"387","author":"Nyang'wa","year":"2022","journal-title":"N Engl J Med"},{"key":"2025031715500293100_ciae560-B4","author":"World Health Organization"},{"key":"2025031715500293100_ciae560-B5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S1473-3099(16)30190-6","article-title":"Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project","volume":"16","author":"Zignol","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2025031715500293100_ciae560-B6","author":"UKHSA"},{"key":"2025031715500293100_ciae560-B7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S2213-2600(15)00466-X","article-title":"Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study","volume":"4","author":"Pankhurst","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2025031715500293100_ciae560-B8","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","article-title":"Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study","volume":"15","author":"Walker","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2025031715500293100_ciae560-B9","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing","volume":"379","author":"CRyPTIC Consortium and the 100,000 Genomes Project","year":"2018","journal-title":"N Engl J Med"},{"key":"2025031715500293100_ciae560-B10","author":"World Health Organization"},{"key":"2025031715500293100_ciae560-B11","author":"UKHSA"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae560\/61019629\/ciae560.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/3\/660\/61019629\/ciae560.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/3\/660\/61019629\/ciae560.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T15:50:36Z","timestamp":1742226636000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/3\/660\/7899844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,13]]},"references-count":11,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,11,13]]},"published-print":{"date-parts":[[2025,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae560","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3,15]]},"published":{"date-parts":[[2024,11,13]]}}}